Bayesian Capital Management’s NOV NOV Stock Holding History
Bought
Maintained
Sold
Other funds holding NOV
FPA
Bayesian Capital Management's NOV Position: Q4 2025 in Review
Bayesian Capital Management sold out of NOV (NOV) in Q4 2025, closing a stake of 21,100 shares — an estimated $280K sold.
Bayesian Capital Management first reported a position in NOV in Q3 2017 and held it in 11 quarters. The position peaked at $1.02M in Q1 2020. 433 funds tracked by Wall St. Rank hold NOV as of Q4 2025.
- Bayesian Capital Management reported no remaining NOV position as of Q4 2025 after selling out during the quarter.
- Bayesian Capital Management sold 21,100 NOV shares in Q4 2025, an estimated $280K.
- Bayesian Capital Management first reported a position in NOV in Q3 2017 and held it in 11 quarters.
- Bayesian Capital Management's NOV position peaked at $1.02M in Q1 2020.
- 433 funds tracked by Wall St. Rank held NOV as of Q4 2025.
Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.